A high-profile researcher and colleagues are urging a range of changes to the 340B program, including new provisions on transparency, [...] Read More »
Category: Federal
The creation of a claims clearinghouse and increasing both the funding and authority of the federal agency overseeing the 340B [...] Read More »
A federal proposal to require the addition of new identifiers to Medicaid drug beneficiaries’ cards to avoid duplicate 340B discounts [...] Read More »
The U.S. Senate Finance Committee yesterday voted 26-1 to pass a pharmacy benefit manager reform bill that would cut providers’ [...] Read More »
More than 100 community health centers, state primary care associations, and national and local groups urged congressional leaders this week [...] Read More »
A hospital that the U.S. Health Resources and Services Administration audited for 340B program compliance and then was one of [...] Read More »
The recently proposed Medicare fee-for-service lump sum payments to 340B hospitals to make up for a nearly five-year unlawful rate [...] Read More »
The U.S. Health Resources and Services Administration (HRSA) this week published notices from drug makers Amgen and Vertex about refunds [...] Read More »
Biopharmaceutical manufacturer Genentech, South Dakota-based health system Sanford Health, and South Carolina federally qualified health center Carolina Health Centers are jointly lobbying members of Congress to back six U.S. senators’ bipartisan approach to federal 340B program reform, the three organizations
Read More »
The U.S. Senate Finance Committee apparently remains on track to vote Wednesday on a pharmacy benefit manager reform bill with [...] Read More »